Outsourced Pharma Capabilities Update May 2026: Highly Potent Drug Development & Manufacturing

This event brings together pharmaceutical and biotech professionals, CDMOs, and technology providers to discuss the development and manufacturing of highly potent active pharmaceutical ingredients (HPAPIs). This event shares presentations focused on key topics such as containment technologies, process scale-up, regulatory compliance, and occupational safety in HPAPI manufacturing. The event also serves as a networking platform where CDMOs showcase their capabilities—such as specialized facilities, containment systems, and expertise in handling highly toxic compounds—allowing pharma and biopharma companies to evaluate potential outsourcing and development partners.

Purpose for attendees:
– Enable CDMOs to present their technical capabilities and facilities for handling potent compounds
– Facilitate partnership discussions and outsourcing opportunities in drug development and manufacturing